chr9-133352134-CTG-C

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_003172.4(SURF1):​c.758_759del​(p.Thr253SerfsTer38) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000876 in 1,598,184 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. T253T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000069 ( 0 hom. )

Consequence

SURF1
NM_003172.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 7.44
Variant links:
Genes affected
SURF1 (HGNC:11474): (SURF1 cytochrome c oxidase assembly factor) This gene encodes a protein localized to the inner mitochondrial membrane and thought to be involved in the biogenesis of the cytochrome c oxidase complex. The protein is a member of the SURF1 family, which includes the related yeast protein SHY1 and rickettsial protein RP733. The gene is located in the surfeit gene cluster, a group of very tightly linked genes that do not share sequence similarity, where it shares a bidirectional promoter with SURF2 on the opposite strand. Defects in this gene are a cause of Leigh syndrome, a severe neurological disorder that is commonly associated with systemic cytochrome c oxidase deficiency. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 34 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-133352134-CTG-C is Pathogenic according to our data. Variant chr9-133352134-CTG-C is described in ClinVar as [Pathogenic]. Clinvar id is 372717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SURF1NM_003172.4 linkuse as main transcriptc.758_759del p.Thr253SerfsTer38 frameshift_variant 8/9 ENST00000371974.8
SURF1NM_001280787.1 linkuse as main transcriptc.431_432del p.Thr144SerfsTer38 frameshift_variant 7/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SURF1ENST00000371974.8 linkuse as main transcriptc.758_759del p.Thr253SerfsTer38 frameshift_variant 8/91 NM_003172.4 P1Q15526-1
SURF1ENST00000615505.4 linkuse as main transcriptc.431_432del p.Thr144SerfsTer38 frameshift_variant 7/81
SURF1ENST00000437995.1 linkuse as main transcriptn.668_669del non_coding_transcript_exon_variant 7/85
SURF1ENST00000495952.5 linkuse as main transcriptn.748_749del non_coding_transcript_exon_variant 4/52

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000135
AC:
3
AN:
221410
Hom.:
0
AF XY:
0.0000168
AC XY:
2
AN XY:
119378
show subpopulations
Gnomad AFR exome
AF:
0.0000728
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000204
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000692
AC:
10
AN:
1445974
Hom.:
0
AF XY:
0.00000557
AC XY:
4
AN XY:
717730
show subpopulations
Gnomad4 AFR exome
AF:
0.0000601
Gnomad4 AMR exome
AF:
0.0000471
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000254
Gnomad4 SAS exome
AF:
0.0000119
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000362
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
152210
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.0000965
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000189

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mitochondrial complex IV deficiency, nuclear type 1 Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingNeuberg Centre For Genomic Medicine, NCGMFeb 14, 2023The frameshift c.758_759del(p.Thr253SerfsTer38) variant has been reported previously in compound heterozygous state in an individual affected with Mitochondrial disorders (Invernizzi F, et. al., 2012). The variant is reported with an allele frequency of 0.001% in the gnomAD exomes database and is novel (not in any individuals) in 1000 Genomes database. This variant has been reported to the ClinVar database as Pathogenic (multiple submissions). This variant causes a frameshift starting with codon Threonine 253, changes this amino acid to Serine residue, and creates a premature Stop codon at position 38 of the new reading frame, denoted p.Thr253SerfsTer38. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitternot providedInstitute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin-- -
Pathogenic, criteria provided, single submitterclinical testingDASAMar 05, 2022The c.758_759delCA;p.(Thr253Serfs*38) is a null frameshift variant (NMD) in the SURF1 gene and predicts alteration of the nonsense-mediate decay - NMD is present in a relevant exon to the transcript - PVS1. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 372717; PMID: 24462369; PMID: 22310368; PMID: 21611066) - PS4. The variant is present at low allele frequencies population databases (rs782349178 – gnomAD 0.0001582%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Thr253Serfs*38) was detected in trans with a pathogenic variant (PMID: 24462369; PMID: 22310368; PMID: 21611066) - PM3. In summary, the currently available evidence indicates that the variant is pathogenic. -
Leigh syndrome Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 30, 2023This sequence change creates a premature translational stop signal (p.Thr253Serfs*38) in the SURF1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 48 amino acid(s) of the SURF1 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with clinical features of Leigh syndrome (PMID: 10443880). This variant disrupts a region of the SURF1 protein in which other variant(s) (p.Arg264Serfs*27) have been determined to be pathogenic (PMID: 23829769, 24462369). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 12, 2016Variant summary: SURF1 c.758_759delCA variant results in a premature termination codon, predicted to cause a truncated or absent SURF1 protein, which is a commonly known mechanism for Leigh Syndrome. Mutation Taster predicts a damaging outcome for this variant, and functional studies from patient fibroblasts (homozygous and compound heterozygous) with this variant show severely impaired complex IV activity. The variant of interest was found in the large, broad control population, ExAC, with an allele frequency of 3/62366 (1/20790), which does not exceed the maximum expected allele frequency for a pathogenic SURF1 variant of 1/565. The variant of interest has been reported in multiple Leigh Syndrome patients in the literature. Taken together, this is a disease variant and was classified as pathogenic. -
not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingGeneDxMay 28, 2019Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Frameshift variant in the C-terminus predicted to result in protein truncation, as the last 48 amino acids are lost and replaced with 37 incorrect amino acids (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 11317352, 23829769, 10443880, 16326995, 21611066, 22310368, 29933018) -
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityAug 31, 2021- -
Leigh syndrome;C4225246:Charcot-Marie-Tooth disease type 4K Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLaboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert EinsteinMay 10, 2021ACMG classification criteria: PVS1 very strong, PS4 supporting, PM2 moderate, PM3 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs782349178; hg19: chr9-136218989; API